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I N T  R O D  U C T  I O N
Excitation–contraction coupling (ECC) is the process 
whereby an electrical signal, depolarization of the 
plasma membrane, is converted into a chemical signal, 
Ca2+ release from the SR, leading to muscle contraction 
(Caputo, 2011). ECC relies on the function of two main 
Ca2+ channels, the voltage-sensing dihydropyridine re-
ceptor (DHPR), an L-type Ca2+ channel present on the 
transverse tubules, and the ryanodine receptor (RyR) 
Ca2+ channel, present on the SR terminal cisternae. In 
mammalian skeletal muscle, ECC is mechanically cou-
pled, that is membrane depolarization causes the α1 
subunit (Cav1.1) of the DHPR to undergo a conforma-
tional change, causing it to come in direct contact with 
the RyR1 and leading to release of Ca2+ from the SR 
(Ríos and Pizarro, 1991). In mammalian cardiac mus-
cles, in contrast, ECC does not rely on mechanical cou-
pling, but rather influx of Ca2+ through the cardiac α1 
subunit of the DHPR (Cav1.2) activates the cardiac 
RyR2, leading to release of Ca2+ from the SR (Bers, 
2002). Thus, the functional requirements of heart and 
skeletal muscle are assured by the exquisite specificity 
of protein isoform expression. This general configura-
tion of skeletal and cardiac ECC protein expression was 
thought to underlie the function of most striated mus-
cles; however, in a recent study on the protein composi-
tion of human extraocular muscles (EOMs), we found 
that hybrid skeletal/cardiac muscle configurations of 
the ECC machinery can exist. Indeed EOMs express 
both the skeletal and cardiac isoforms of the α1 subunit 
of the DHPR, rely on influx of Ca2+ from the extracellu-
lar environment, and express not only RyR1 but also 
RyR3 (Sekulic-Jablanovic et al., 2015).
EOMs, the fastest muscles in the body, derive from 
somitomeres (preotic mesodermal segments; Wright et 
al., 2006). There are six EOMs distributed in three an-
tagonistic pairs of muscles that finely control eye move-
ments (Spencer and Porter, 1988); they are innervated 
by three cranial nerves (III, IV, and VI; Sadeh and Stern, 
1984). EOMs are highly specialized and can be either 
singly innervated or multiply innervated. These charac-
teristics together with the unique expression of myosin 
heavy chain–EO (MyHC13; Schiaffino and Reggiani, 
2011) set them apart from all other skeletal muscles, as 
a distinctive group of highly specialized muscles (Spen-
cer and Porter, 1988). In contrast, the orbicularis oculi 
muscles comprise the sphincter muscles of the eyelids; 
they are classified as facial muscles and functionally an-
tagonize the levator palpebrae superioris muscles, 
The orbicularis oculi are the sphincter muscles of the eyelids and are involved in modulating facial expression. 
They differ from both limb and extraocular muscles (EOMs) in their histology and biochemistry. Weakness of the 
orbicularis oculi muscles is a feature of neuromuscular disorders affecting the neuromuscular junction, and weak-
ness of facial muscles and ptosis have also been described in patients with mutations in the ryanodine receptor 
gene. Here, we investigate human orbicularis oculi muscles and find that they are functionally more similar to 
quadriceps than to EOMs in terms of excitation–contraction coupling components. In particular, they do not 
express the cardiac isoform of the dihydropyridine receptor, which we find to be highly expressed in EOMs where 
it is likely responsible for the large depolarization-induced calcium influx. We further show that human orbicularis 
oculi and EOMs express high levels of utrophin and low levels of dystrophin, whereas quadriceps express dystro-
phin and low levels of utrophin. The results of this study highlight the notion that myotubes obtained by explant-
ing satellite cells from different muscles are not functionally identical and retain the physiological characteristics 
of their muscle of origin. Furthermore, our results indicate that sparing of facial and EOMs in patients with 
Duchenne muscular dystrophy is the result of the higher levels of utrophin expression.
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which are accessory EOMs (Porter et al., 1998). The or-
bicularis oculi muscles can be subdivided into orbital, 
palpebral, and lacrimal portions. The orbital portion 
firmly closes the eyelids and is controlled by voluntary 
action; the palpebral portion closes the eyelids gently in 
involuntary or reflex blinking; the palpebral portion 
can be further divided into pretarsal, preseptal portion, 
and ciliary. The lacrimal portion compresses the lacri-
mal sac, which receives tears from the lacrimal ducts 
and conveys them into the nasolacrimal duct (Gray and 
Lewis, 1918). The orbicularis oculi muscles derive from 
the mesenchyme in the second pharyngeal arch (Moore 
et al., 2015) and are innervated by the VII cranial nerve 
(Ouattara et al., 2004).
Weakness of the orbicularis oculi muscles is often ap-
parent in neuromuscular disorders affecting the neuro-
muscular junction (Miller et al., 2008). Similar to EOMs, 
they are also one of the first targets of mitochondrial 
myopathies and myasthenia gravis, resulting in weakness 
of eyelid closure and ptosis (Miller et al., 2008). Facial 
weakness and ptosis have also been described in patients 
with recessive RYR1 mutations (the gene encoding the 
RyR1; Taylor et al., 2012), affected by multiminicore dis-
ease, congenital fiber type disproportion, and centronu-
clear disease (Jungbluth et al., 2005; Treves et al., 2008; 
Clarke et al., 2010; Wilmshurst et al., 2010). In contrast, 
EOMs are spared in aging, Duchenne muscular dystro-
phy, and congenital muscular dystrophy when all other 
skeletal muscles are affected (Kaminski et al., 1992; Khu-
rana et al., 1995; Kallestad et al., 2011). Weakness of 
the facial musculature caused by any disease is almost 
certainly accompanied by weakness of the orbicularis 
oculi muscles as well (Miller et al., 2008). The present 
investigation was undertaken to identify similarities and 
differences in ECC and calcium homeostasis in human 
EOMs, orbicularis oculi, and quadriceps, to identify fac-
tors that might contribute to the selective involvement 
in different neuromuscular disorders. The results of 
the present investigation show that the ECC machin-
ery and calcium regulation of human orbicularis oculi 
are more similar to those of quadriceps than of EOMs; 
in contrast, orbicularis oculi and EOMs are similar in 
that they both express high levels of utrophin, whereas 
quadriceps expresses dystrophin. This finding explains 
the sparing of facial and EOMs in Duchenne patients; 
because the ECC machinery between orbicularis oculi 
and quadriceps appears to be similar, our study points 
to a potential use of autologous facial muscle–derived 
satellite cells for muscle reimplantation in patients with 
muscular dystrophy.
M AT  E R I  A L S  A N D  M E T  H O D S
Human muscle cell cultures
Primary muscle cell cultures were established as pre-
viously described (Censier et al., 1998; Ducreux et al., 
2004) from fragments of muscle biopsies from patients 
aged between 18 and 65 yr. Quadriceps muscle biopsies 
were obtained from healthy males or females (six do-
nors) undergoing in vitro diagnostic procedures, orbicu-
laris oculi muscle biopsies were from preseptal muscles 
of patients (≈75% females) undergoing eyelid cosmetic 
procedure or blepharoplasty (five donors), and EOM 
biopsies were from lateral or medial rector muscles of 
patients undergoing squint corrective surgery (four do-
nors). Cells were plated on laminin-coated glass covers-
lips and allowed to grow and differentiate as previously 
described (Treves et al., 2011; Sekulic-Jablanovic et al., 
2015). This research was performed in accordance with 
the Declaration of Helsinki (2013) of the World Med-
ical Association and was approved by the Ethikkom-
mission beider Basel (permit N° EK64/12); all subjects 
gave written informed consent to carry out this work.
Calcium measurements and spark analysis
Fura-2/AM (EMD Millipore) or fluo-4/AM (Thermo 
Fisher Scientific) at a final concentration of 5 µM was 
used to load myotubes for 30 min at 37°C, after which 
the coverslips were mounted onto a 37°C thermostati-
cally controlled chamber that was continuously per-
fused with Krebs-Ringer medium; individual cells were 
stimulated by means of a 12- or 8-way 100-mm-diameter 
quartz micromanifold computer-controlled microper-
fuser (ALA Scientific Instruments), as described previ-
ously (Ducreux et al., 2004). The ratiometric Ca2+ 
indicator fura-2 was used for monitoring the global 
changes in the cytoplasmic Ca2+ concentration as previ-
ously described (Censier et al., 1998; Ducreux et al., 
2004). Ratiometric images (340/380 nm) were acquired 
every 1  s, and the camera was set at a fixed exposure 
time of 100 ms. Fura-2 fluorescence ratio signals were 
converted into [Ca2+] using the curve generated using 
the fura-2 Ca2+ imaging calibration kit from Molecular 
Probes as previously described (Vukcevic et al., 2013). 
The total amount of rapidly releasable Ca2+ in the stores 
was determined as previously described (Rokach et al., 
2013) by calculating the area under the curve of the 
transient induced by the application of 1 µM ionomy-
cin, plus 1  µM thapsigargin in Krebs-Ringer contain-
ing 0.5 mM EGTA.
The dynamics of depolarization-induced Ca2+ influx 
were investigated by total internal reflection fluores-
cence (TIRF) microscopy using the single wavelength 
Ca2+ indicator fluo-4 as detailed previously (Treves et 
al., 2011; Ullrich et al., 2011). Myotubes were pretreated 
with 50 µM ryanodine (EMD Millipore) to block Ca2+ 
release through the RyR1 receptor (Treves et al., 2011), 
and depolarization-induced Ca2+ entry was stimulated 
by the application of 60 mM KCl. Online fluorescence 
images were acquired every 100 ms using an inverted 
Nikon TE2000 TIRF microscope equipped with an oil 
immersion CFI Plan Apochromat 60× TIRF objective 
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(1.49 NA) and an electron multiplier Hamamatsu CCD 
camera (C9100-13). The MetaMorph imaging software 
from Molecular Devices was used for analysis of the 
fluorescence changes.
Quantitative real-time PCR (qPCR)
Total RNA was extracted from muscle biopsies using 
TRIzol (Invitrogen) according to the manufacturer’s 
instructions. RNA was first treated with deoxyribonu-
clease I (Invitrogen), and then 1,000 ng was reverse 
transcribed using the high-capacity cDNA reverse tran-
scription kit (Applied Biosystems). cDNA was ampli-
fied by qPCR using SYBR Green technology (Fast SYBR 
Green Master Mix; Applied Biosystems) as previously 
described (Rokach et al., 2013). The sequences of the 
primers used for gene amplification and quantification 
are given in Table S1. qPCR was performed on a 7500 
Fast Real-Time PCR machine (Applied Biosystems) 
using the 7500 software v2.3 as previously described 
(Sekulic-Jablanovic et al., 2015). Gene expression was 
normalized to expression of ACTN2, which is pres-
ent in all muscle fiber types. Results are expressed as 
fold change compared with expression of the gene in 
quadriceps muscles.
Immunofluorescence
Differentiated human myotubes grown on a glass cov-
erslip coated with laminin were fixed with 4% para-
formaldehyde (made in PBS), permeabilized with 1% 
Triton in PBS for 20 min, and processed as previously 
described (Treves et al., 2011). The following antibod-
ies were used: mouse anti-RyR1 (MA3-925; Thermo 
Fisher Scientific), goat anti-Cav1.1 (sc-8160; Santa Cruz 
Biotechnology, Inc.), rabbit anti-Cav1.2 (sc-25686; Santa 
Cruz Biotechnology, Inc.), mouse anti-dystrophin (ab-
7164; Abcam), rabbit anti-utrophin (sc-15377; Santa 
Cruz Biotechnology, Inc.), Alexa Fluor 488–conju-
gated chicken anti–rabbit, Alexa Fluor 555–conjugated 
donkey anti–goat IgG (Thermo Fisher Scientific), 
and Alexa Fluor 647–conjugated goat anti–mouse IgG 
(Thermo Fisher Scientific). Cells were stained with 4′, 
6-diamidino-2-phenylindole (DAPI; Thermo Fisher Sci-
entific) to visualize nuclei and observed using an A1R 
confocal microscope (Nikon) with a CFI Apo TIRF 
100× (1.49 NA) objective.
Electrophoresis and immunoblotting
The total SR fraction was isolated from flash-frozen 
muscle samples (human orbicularis oculi, EOM, quad-
riceps muscles, and mouse heart) as previously de-
scribed (Anderson et al., 2003) and stored in liquid 
nitrogen. The protein concentration was determined 
using the Protein Assay kit II (Bio-Rad Laboratories) 
and BSA as a standard. SDS-PAGE, protein transfer on 
to nitrocellulose membranes, and immunostaining 
were performed as previously described (Anderson et 
al., 2003). The following primary antibodies were used: 
mouse anti-RyR1 (MA3-925; Thermo Fisher Scientific), 
goat anti-Cav1.1 (sc-8160; Santa Cruz Biotechnology, 
Inc.), rabbit anti-Cav1.2 (sc-25686; Santa Cruz Biotech-
nology, Inc.), rabbit anti–calsequestrin 1 (C-0743; Sig-
ma-Aldrich), anti–calsequestrin 2 (3516; Abcam), goat 
anti-SER CA1 (sc-8093; Santa Cruz Biotechnology, Inc.), 
mouse anti-sarcalumenin (SRL; MA3-932; Thermo 
Fisher Scientific), anti-dystrophin (ab-7164; Abcam), 
anti-utrophin (sc-15377; Santa Cruz Biotechnology, 
Inc.), and mouse anti–myosin heavy chain (05-716; 
EMD Millipore). Secondary peroxidase conjugates were 
protein G–peroxidase (P8170; Sigma-Aldrich) and per-
oxidase-conjugated goat anti–mouse IgG (A2304; Sig-
ma-Aldrich). The immunopositive bands were visualized 
by chemiluminescence using the Super Signal West 
Dura kit (Thermo Fisher Scientific) or the Chemilumi-
nescence kit (Roche). 
For myosin heavy chain, gels were performed as de-
scribed by Talmadge and Roy (1993) except that 30 µg 
total protein extracts were separated and the final acryl-
amide concentration was 6.5%. Gels were stained with 
Coomassie brilliant blue.
Statistical analysis
Statistical analysis was performed using the Student’s 
t test for two populations. Values were considered sig-
nificant when P < 0.05. When more than two groups 
were compared, analysis was performed by the ANO 
VA test followed by the Bonferroni post hoc test, using 
Prism 4.0 software (GraphPad Software). OriginPro 8.6 
software (OriginLab) was used for generating dose–
response curves.
Methods used in supplemental material
Voltage dependence of Ca2+ release. Orbicularis oculi–
derived myotubes were patch clamped in the whole cell 
configuration and stimulated to different depolarizing 
potentials to elicit SR Ca2+ release as previously reported 
using a EPC10 amplifier (HEKA) controlled by the data 
acquisition software PatchMaster (Rokach et al., 2013). 
External recording solution contained (mM) 130 TEA-
CH3SO3, 2 CaCl2, 1 MgCl2, 10 HEP ES, 1  µM tetrodo-
toxin, and 1 4-aminopyridine, pH 7.4 (CsOH). Internal 
pipette solution contained (mM) 100 Cs-CH3SO3, 10 
HEP ES, 6 MgCl2, 11.5 CaCl2, 4 Na2ATP, 10 EGTA, and 
0.1 K5-fluo-3, pH 7.2 (CsOH). Solution exchange was 
controlled by an electrically controlled rapid switch mi-
croperfuser (VC8; Ala Scientific Instruments). Starting 
from a holding potential of −80 mV, the voltage clamp 
protocol consisted of consecutive depolarizing 500-ms 
step pulses to increasing potentials ranging from −50 to 
50 mV with an increment of 10 mV. In parallel, changes 
in cytosolic Ca2+ in clamped cells were recorded by im-
aging of the fluorescent Ca2+-sensitive indicator fluo-3 
using a confocal microscope in the line scan mode 
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(IX81, FluoView FV1000, 60× water objective, NA 1.2; 
Olympus). Excitation of fluo-3 was achieved at 473 nm, 
and emission was collected between 510 and 560 nm. 
Line scans were acquired at a rate of 5.6 ms per line. To 
acquire multiple line scans from each cell, the duration 
of the single line scan image was limited to 1,000 lines 
to avoid photobleaching and cell damage. Experiments 
were performed at constant room temperature. Images 
were analyzed using ImageJ (National Institutes of 
Health) and further processed together with current 
analysis in OriginPro 2015 software.
Spark measurements. Sparks were measured in fluo-4–
loaded myotubes using an A1R laser-scanning confocal 
microscope (Nikon) with a 60× oil immersion Plan Apo-
chromat VC objective (Nikon; NA 1.4) as previously de-
scribed (Lopez et al., 2015). 5-s duration line scan 
images (x,t) were acquired in resonant mode at 7,680 
lps with 512 pixels (0.05 µm/pixel) in the x and 39,936 
pixels (0.126 ms/pixel) in the t direction using a pin-
hole size of 72.27 µm. Four to five images were taken at 
different positions across each cell. The Ca2+ indicator 
was excited with a laser at 487 nm, and the fluorescence 
emitted at 525 ± 25 nm was recorded. To minimize 
photo damage, the laser intensity was set at 3∼4% of the 
maximal power. Cells were perfused with Krebs-Ringer 
containing 2 mM Ca2+.
Online supplemental material
Fig. S1 shows the voltage dependence of Ca2+ release 
in orbicularis oculi–derived myotubes. Fig. S2 shows 
that human myotubes do not show spontaneous Ca2+ 
release events (SPA RKS). Table S1 lists the sequence of 
primers used for qPCR. Online supplemental material 
is available at http ://www .jgp .org /cgi /content /full /
jgp .201511542 /DC1.
R E S  U LT S
Gene and protein expression levels in human orbicularis 
oculi, EOM, and quadriceps muscles
The expression levels of the major gene products in-
volved in skeletal ECC are shown in Fig. 1 A; the values 
obtained from orbicularis oculi were compared with 
those obtained from quadriceps of healthy donors. The 
latter muscles were used as reference, and the expres-
sion level of different genes therein was set to 1. The 
results show the mean (±SEM) expression level of genes 
from five pooled biopsy samples normalized to ACTN2. 
The expression of RYR1 and SER CA1 transcripts was 
slightly elevated (approximately twofold; P < 0.05, Stu-
dent’s t test), as was that of CASQ1, RYR3, and CAC 
NA1C (4-, 5-, and 10-fold, respectively; P < 0.0001, Stu-
dent’s t test), whereas CAC NA1S expression was similar 
in orbicularis oculi and quadriceps muscles. Interest-
ingly, the expression levels of UTRN and DMD showed 
an ∼13- and 16-fold increase, respectively, compared 
with quadriceps muscles (P < 0.0001, Student’s t test). 
Although it was reported that the MYH13 isoform is ex-
clusively expressed in EOMs (Wieczorek et al., 1985), 
we also found that it is expressed in orbicularis oculi 
(Fig. 1 B). JP45 levels remained unchanged.
Total SR fractions were prepared and probed with 
antibodies against the major skeletal ECC proteins as 
well as Cav1.2 and CASQ2; the intensities of the immu-
noreactive bands were normalized to SRL content and 
are expressed as percent expression of that of quadri-
ceps muscles. Surprisingly, at the protein level, the 
content of RyR1, Cav1.1, SER CA1, and CASQ1 were 
not changed between orbicularis oculi and quadriceps 
(Fig. 1 C), whereas CASQ2 was significantly increased. 
We chose to normalize to SRL content and not to SER 
CA1 or CASQ1 because by qPCR both SER CA1 and 
CASQ1 transcripts were significantly increased in orbi-
cularis oculi. Cav1.2, the cardiac isoform of the DHPR, 
could not be detected in Western blots of orbicularis 
oculi and quadriceps, but it was clearly present in 
human EOM and mouse heart, which served as posi-
tive control (Fig. 1 D). Utrophin was highly expressed 
in both EOM and orbicularis oculi but less so in quad-
riceps (fourfold in orbicularis oculi vs. quadriceps; P < 
0.05), whereas the opposite was true for dystrophin 
(orbicularis oculi expressed ∼50% compared with 
quadriceps; P < 0.05; Fig. 1 E).
Ca2+ homeostasis in human myotubes derived from 
orbicularis oculi, EOM, and quadriceps
Because in a previous study we showed that primary 
cultures of myotubes explanted from human EOM bi-
opsies had different Ca2+ handling properties (Seku-
lic-Jablanovic et al., 2015), in the next series of 
experiments we compared Ca2+ homeostasis in myo-
tubes derived from the three types of muscles. In this 
context, it should also be mentioned that human myo-
tubes are different from mouse myotubes or fibers in 
that they do not contract even after exposure to high 
concentrations of KCl, 4-chloro-m-cresol (4-cmc) or 
ionomycin plus thapsigargin. In the first set of experi-
ments, cells were perfused with Krebs-Ringer contain-
ing 100 µM La3+ to prevent influx of extracellular Ca2+ 
and to ensure that the measurements represent skeletal 
ECC. Fig.  2  A shows representative fura-2 traces of a 
quadriceps-derived myotube (continuous line), orbicu-
laris oculi–derived myotube (dashed line), and EOM-de-
rived myotube (dotted line) in response to 60 mM KCl. 
Fig. 2 (B and C) shows the KCl- and 4-cmc–induced Ca2+ 
release curves, respectively. There were no significant 
differences between the three types of myotubes as far 
as peak Ca2+ release elicited by either KCl or 4-cmc is 
concerned. Furthermore, the EC50 for KCl (depolariza-
tion)-induced Ca2+ release was similar in the three types 
of myotubes, whereas the EC50 for 4-cmc–induced Ca2+ 
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release was significantly different only between orbicu-
laris oculi– and EOM-derived myotubes (Table 1). We 
also verified the voltage dependence of Ca2+ release of 
orbicularis oculi–derived myotubes; the half-maximal 
release activation V1/2 was −25 ± 5 mV (Fig. S1), a value 
similar to that previously reported in quadriceps-de-
rived myotubes (Rokach et al., 2013), confirming that 
the ECC is very similar in both kinds of myotubes. Inter-
estingly, however, there were differences in the mean 
global resting [Ca2+]i in the three populations of myo-
tubes, though we could not ascertain whether this was 
caused by large differences within cytoplasmic micro/
Figure 1. Expression of major ECC transcripts and proteins in human orbicularis oculi muscle biopsies. (A) Gene expression was 
performed by qPCR as described in Materials and methods. Each reaction was performed in triplicate, in pooled muscle samples from 
five biopsies from different individuals. Expression levels were normalized to ACTN2 expression. Results are expressed as mean fold 
change of transcripts in orbicularis oculi compared with quadriceps; the latter was set as 1. Results were analyzed using the Student’s 
t test: *, P < 0.05; ***, P < 0.0001. (B) MYH13 gene expression was performed by qPCR as described in Materials and methods. Each 
reaction was performed in triplicate, in pooled muscle samples from five biopsies from different individuals. Expression levels were 
normalized to ACTN2 expression. Results are expressed as mean fold change of transcripts in orbicularis oculi (OO) compared with 
quadriceps (QU); the latter were set as 1. Results were analyzed using the Student’s t test: ***, P < 0.0001. The inset shows MyHC 
protein expression in EOM and orbicularis oculi muscle homogenates; 10 and 30 µg protein were loaded per lane, respectively. Gels 
and conditions were as described in Materials and methods. (C) Western blot analysis of total SR proteins in human orbicularis oculi 
and quadriceps muscles. 30 µg of protein was loaded per lane and separated on 6% or 10% SDS‑PAGE. Blots were probed with the 
indicated antibodies. Bar histograms represent the mean (±SEM) band intensity normalized to SRL content. *, P < 0.05. (D) Western 
blot of human quadriceps, EOM, orbicularis oculi, and mouse heart (positive control) total SR proteins, probed with Cav1.2 antibody. 
30 µg of protein was loaded per lane and separated on 6% SDS‑PAGE. (E) Western blot of total muscle extracts; 30 µg of protein 
was loaded per lane, separated on 6% SDS‑PAGE, and probed with anti‑utrophin (top) and anti‑dystrophin (bottom) antibodies. Bar 
histograms represent the mean (±SEM) band intensity normalized to MyHC content. Student’s t test: *, P < 0.05.
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nanodomains or by a uniform difference resulting from 
the presence, for example, of different cytoplasmic cal-
cium buffering proteins. The size of the intracellular 
Ca2+ stores of orbicularis oculi–derived myotubes was 
similar to those of quadriceps-derived myotubes but sig-
nificantly lower than those of EOM-derived myotubes 
(Fig. 2, C and D; P < 0.0001, Student’s t test). We also 
examined the different types of myotubes for the pres-
ence of Ca2+ sparks by high-speed confocal microscopy, 
but none of the myotubes exhibited sparks (Fig. S2).
We next investigated the process by which membrane 
depolarization activates Ca2+ influx through the DHPR- 
or depolarization-induced Ca2+ influx (Bannister et al., 
2009) by TIRF microscopy as previously described 
(Treves et al., 2011). Fig.  3  A shows pseudocolored 
fluo-4 fluorescent changes in a representative myotube 
pretreated with 50 µM ryanodine and stimulated with 
60 mM KCl; the pretreatment with high concentrations 
of ryanodine is necessary to block Ca2+ release through 
RyR, ensuring that the change in fluo-4 fluorescence is 
not caused by Ca2+ release from the SR, but rather from 
Figure 2. Calcium homeostasis of orbicularis oculi–derived myotubes compared with quadriceps- and EOM-derived myo-
tubes. (A) Representative traces showing changes in [Ca2+]i induced by stimulation with KCl. Individual cells were perfused in Krebs‑
Ringer containing 100 µM La3+ (light gray bar) and then stimulated with 60 mM KCl for 10 s (black bar). Ratiometric images (340 
nm/380 nm) were acquired and converted into [Ca2+] as described in Materials and methods. Continuous line, quadriceps‑derived 
myotubes; dashed line, orbicularis oculi–derived myotubes; dotted line, EOM‑derived myotubes. (B and C) KCl dose–response 
curves (B) and 4‑cmc dose–response curves (C). Closed circles and continuous lines, quadriceps‑derived myotubes; open circles and 
dashed lines, orbicularis oculi–derived myotubes; open squares and dotted lines, EOM‑derived myotubes. Curves were generated 
using the sigmoidal fit function of the Origin software and show the changes in peak calcium, expressed as [Ca2+] in nM. Each point 
represents the mean (±SEM) of 5–12 different cells. For KCl‑ and 4‑cmc–induced Ca2+ release, individual cells were perfused with 
Krebs‑Ringer plus 100 µM La3+, and the indicated concentration of agonist was applied using a microperfusion system. (D) Mean 
(±SEM) resting [Ca2+]. *, P < 0.05; **, P < 0.001. (E) Total amount of Ca2+ in the SR. Values represent the mean (±SEM) calculated 
area under the curve. Student’s t test: ***, P < 0.0001. For quadriceps (QU)‑derived myotubes, cells from six donors were measured; 
for orbicularis oculi (OO)–derived myotubes, cells from five donors were measured; and for EOM‑derived myotubes, cells from four 
donors were measured.
Table 1. EC50 for KCl- and 4-cmc–induced Ca2+ release from 
myotubes from human quadriceps, orbicularis oculi, and EOMs
Tissue of origin KCl EC50 4-cmc EC50a
mM µM
Quadriceps 16.0 ± 2.0 234.0 ± 58
Orbicularis oculi 19.5 ± 4.0 206.6 ± 24b
EOM 10.2 ± 5.0 332.0 ± 26
aANO VA did not reveal any differences in the EC50 to KCl between the three 
types of myotubes. Significant differences were obtained in the EC50 to 4-cmc, 
and the Bonferroni post hoc test confirmed the difference to be significant 
between EOM- and orbicularis oculi–derived myotubes.
bP < 0.02.
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Ca2+ influx. Fig. 3 B shows a representative Ca2+ influx 
trace initiated by the application of 60 mM KCl in orbi-
cularis oculi–derived myotubes (solid trace) quadriceps- 
derived myotubes (dashed trace), and EOM-derived 
myotubes (dotted trace). A control experiment per-
formed on EOM-derived myotubes showing that no 
Ca2+ influx occurs when the same experiment is per-
formed in the presence of 100 µM La3+ is also shown 
(dash-dotted trace). Fig.  3  C summarizes the results 
confirming that depolarization-induced Ca2+ influx in 
orbicularis oculi myotubes is not significantly different 
from quadriceps myotubes, but almost threefold lower 
compared with EOM-derived myotubes.
The difference in Ca2+ influx between EOM and orbi-
cularis oculi muscles most likely reflects the differential 
expression of Cav isoforms in these groups of muscles. 
This is confirmed by results depicted in Fig. 4 showing 
the subcellular distribution of Cav1.1, Cav1.2, and RyR1 
in orbicularis oculi– and EOM-derived myotubes; the dis-
tribution of Cav1.1 (Fig. 4 A, green) and RyR1 (Fig. 4 B, 
red) was punctate and unstructured within an intracellu-
lar membrane compartment. Although they lack a ma-
ture organization, RyR1 and Cav1.1 codistributed within 
the myotube (Fig. 4 C). However, Cav1.2 could not be 
detected in orbicularis oculi–derived myotubes 
(Fig. 4 D). A similar subcellular punctate distribution of 
Cav1.1 (Fig.  4  E) and RyR1 (Fig.  4  F) was found in 
EOM-derived myotubes; however, in the latter cells, 
Cav1.2 was exclusively targeted to the plasma mem-
brane (Fig. 4 H).
Dystrophin and utrophin expression and subcellular 
distribution in myotubes derived from orbicularis oculi, 
EOM, and quadriceps
Because qPCR and Western blot analysis revealed that 
orbicularis oculi and EOM but not quadriceps muscle 
biopsies express high levels of utrophin, we investi-
gated by confocal microscopy the expression and distri-
bution of dystrophin and utrophin in the different 
kinds of myotubes. Quadriceps-derived myotubes 
(Fig. 5, A–D) showed punctate distribution of dystro-
phin, with some patches close to the plasma membrane 
(Fig.  5  B), but were negative for utrophin staining 
(Fig. 5 C). Orbicularis oculi–derived myotubes (Fig. 5, 
E–H) also showed a punctate distribution of dystro-
phin (Fig. 5 F); these myotubes were also positive for 
utrophin whose distribution was less homogeneous, 
had a more filamentous appearance, and was concen-
trated in areas around the cell periphery (Fig.  5  G). 
EOM-derived myotubes (Fig. 5, I–L) were similar to or-
bicularis oculi–derived myotubes in that dystrophin 
had a punctate distribution (Fig.  5  J), whereas utro-
phin was distributed less homogeneously, had a fila-
mentous appearance, and was concentrated in areas 
around the cell periphery (Fig.  5  K). Interestingly, 
utrophin and dystrophin appeared to have a separate 
Figure 3. Depolarization-induced Ca2+ 
influx in orbicularis oculi–, EOM-, and 
quadriceps-derived myotubes. Ca2+ in‑
flux induced by the addition of 60  mM 
KCl was monitored using a TIRF micro‑
scope as described in Materials and 
methods and detailed in Treves et al. 
(2011). (A) Pseudocolored ratiometric 
images of fluorescence changes (peak 
fluorescence after addition of KCl/resting 
fluorescence) after application of 60 mM 
KCl to orbicularis oculi–derived myo‑
tubes. 1, EpiSRIC image; 2–5, images at 
2, 5, 11, and 20  s after the addition of 
KCl. The dark gray area within the EpiS‑
RIC image showing the “footprint” of the 
cell on the glass coverslip was used as a 
template to draw a mask of the region 
of interest where calcium changes were 
measured. Bar, 30 µm. (B) Representative 
depolarization‑induced Ca2+ influx traces 
in quadriceps‑derived (continuous line), 
orbicularis oculi–derived (dashed line), 
and EOM‑derived myotubes (dotted 
line). The black bar indicates the addition 
of 60 mM KCl. The gray line shows the lack of response of an EOM‑derived myotube when the experiment was performed in a 
solution containing 100 µM La3+. (C) Mean (±SEM) peak fluorescence increase induced by 60 mM KCl in quadriceps (QU)‑derived 
myotubes (black bar), orbicularis oculi (OO)–derived myotubes (white bar), and EOM‑derived myotubes (gray bar). Experiments 
were performed on cells obtained from at least four different biopsies, and results were averaged. Statistical analysis was performed 
using the ANO VA test: ***, P < 0.0001.
 o
n
 April 26, 2016
jgp.rupress.org
D
ow
nloaded from
 
Published April 11, 2016
Subspecialization of human ocular muscles | Sekulic‑Jablanovic et al.402
subcellular distribution that does not overlap within 
the myotubes (Fig. 5, H and L).
D I S  C U S  S I O N
In the present study, we investigated the biochemical 
and physiological characteristics of orbicularis oculi 
muscles, a group of facial muscles that are selectively 
spared or involved in different neuromuscular disor-
ders. As far as the expression of proteins involved in 
ECC is concerned, it appears that orbicularis oculi mus-
cles are closer to quadriceps than to EOMs. Indeed, the 
content of skeletal muscle SR proteins was similar be-
tween quadriceps and orbicularis oculi muscles and dif-
fered from that of EOMs, as only the latter express 
proteins characteristic of both cardiac and skeletal mus-
cle ECC (Sekulic-Jablanovic et al., 2015). Surprisingly, 
however, the expression of transcripts did not always 
match the actual protein content, highlighting the im-
portance of validating arrays or qPCR experiments 
whenever possible. This was particularly relevant for the 
difference between the expression of Cav1.2 and dystro-
phin whose transcripts were increased >8–10-fold in or-
bicularis oculi, but at the protein level they were barely 
detectable. An intriguing result of this study is that al-
though gene expression in orbicularis oculi is quite dif-
ferent from that in quadriceps, the expression of 
proteins involved in the ECC process (RyR1, Cav1.1, 
SER CA1, CASQ1, and Cav1.2) is similar in both cell 
types. In contrast, in our previous study, the differences 
in gene expression between EOM and quadriceps were 
positively correlated with differences in the expression 
of ECC proteins (Sekulic-Jablanovic et al., 2015). The 
reason for this discrepancy is at present unclear, but 
agreement between mRNA and protein content occurs 
only ∼40% of the time and is influenced by different 
Figure 4. Cellular distribution of 
RyR1 and Cav1.1 in differentiated 
orbicularis oculi–derived myotubes. 
Human myotubes were visualized with 
an A1R confocal microscope equipped 
with a CFI Apo TIRF 100× objective 
(1.49 NA) and stained as described 
in Materials and methods. Top pan‑
els show orbicularis oculi, and bottom 
panels show EOMs. (A and E) An‑
ti‑Cav1.1 (green). (B and F) Anti‑RyR1 
(red). (C and G) Merged image of an‑
ti‑RyR1, anti‑Cav1.1, and DAPI (blue); 
orange pixels show codistribution of 
RyR1 and Cav1.1. (D and H) Anti‑Cav1.2 
(green). Bars, 20 µm.
Figure 5. Cellular distribution of dystrophin 
and utrophin in differentiated myotubes. 
Human myotubes were visualized with an A1R 
confocal microscope equipped with a CFI Apo 
TIRF 100× objective (1.49 NA) and stained as 
described in Materials and methods. (A–D) 
Quadriceps‑derived myotubes. (E–H) Orbicularis 
oculi–derived myotubes. (I–L) EOM‑derived myo‑
tubes. (A, E, and I) Brightfield images. (B, F, and J) 
Anti‑dystrophin. (C, G, and K) Anti‑utrophin and 
DAPI. (D, H, and L) Merged images. Bars, 10 µm.
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factors, including mRNA and protein stability, the pres-
ence of microRNAs, and posttranscriptional modifica-
tions, with the key role in determining protein 
abundance being played at the level of translation (Tian 
et al., 2004; Vogel et al., 2010; Schwanhäusser et al., 
2011). A limited overlap in genomic and proteomic 
data were reported by Khanna et al. (2003) in EOM and 
leg muscles and by Zhou et al. (2010) in mouse EOM 
myosin heavy chain isoform expression.
From a point of view of calcium homeostasis, it ap-
pears that orbicularis oculi muscle–derived myotubes 
are closer to those derived from quadriceps than 
EOM because the Ca2+ release dose–response curves, 
the voltage dependence of Ca2+ release, the resting 
[Ca2+], and ionomycin/thapsigargin-sensitive intracel-
lular stores from the two muscle types were function-
ally indistinguishable and were clearly different from 
EOM-derived myotubes. The latter have a significantly 
higher EC50 for 4-cmc–induced Ca2+ release, larger 
ionomycin/thapsigargin-sensitive intracellular stores, 
express Cav1.2, and exhibit a threefold larger depolar-
ization-induced Ca2+ influx. The difference in sensitiv-
ity to 4-cmc–induced Ca2+ release but not KCl-induced 
Ca2+ release may reflect the different amounts of RyR1 
and RyR3 expressed in EOM-derived myotubes. Such a 
hypothesis is compatible with previous findings (Fessen-
den et al., 2000; Matyash et al., 2002; Sekulic-Jablanovic 
et al., 2015) who showed that (a) EOM biopsies contain 
∼100-times more RYR3 transcript than triceps biopsies, 
whereas orbicularis oculi express only ∼4-times more; 
(b) RyR3 have a significantly lower sensitivity to 4-cmc; 
and (c) in reconstituted 1B5 myotubes, RyR3 cannot 
form functional contacts with the DHPR and there-
fore would not contribute directly to the KCl-induced 
Ca2+ release.
One of the physiological characteristics of EOMs is 
that they are fatigue resistant (Fuchs and Binder, 1983), 
and this may be functionally related to the high levels of 
expression of Cav1.2 and consequent large Ca2+ influx. 
The Ca2+ influx may be used as a means (a) to activate 
ECC more rapidly by enhancing Ca2+ induced Ca2+ re-
lease or (b) to rapidly replenish intracellular stores. De-
polarization-induced Ca2+ influx is less pronounced in 
myotubes derived from other skeletal muscles, most 
likely because they lack the cardiac isoform of the 
α1 DHPR subunit.
Although orbicularis oculi express a typical skeletal 
muscle ECC, they also show similarities with EOMs in 
that they express MyHC13 and high levels of RYR3. In 
humans, orbicularis oculi are composed of 90% type II 
fibers and 10% type I fibers (Wirtschafter et al., 1994; 
Campbell et al., 1999), but our results show that they 
also express MyH13. In a study on levator palpebrae 
and retractor bulbi muscles from different species, it 
was shown that the latter muscles also express MyHC13 
and that this is probably responsible for their rapid 
contracture times (<10 ms); in fact, limb muscles do 
not express the superfast myosin isoforms, and their 
contracture time is approximately five times longer 
(Lucas and Hoh, 1997). As far as RYR3 expression is 
concerned, our results are enigmatic because, in gen-
eral, RYR3 transcripts are expressed at low levels, if at 
all, in adult skeletal muscle (Martin et al., 1998), and 
the role of RyR3 is unclear. RYR3KO mice are viable, 
and their muscles show no obvious physiological differ-
ences compared with their wild-type littermates, includ-
ing no changes in electrically induced Ca2+ release and 
contractile properties of adult muscle fibers, although 
skeletal muscles from neonatal RYR3 KO mice show de-
creased tension development (Takeshima et al., 1996). 
Although for the time being the function of RyR3s is 
speculative, it is possible that these channels act as am-
plifiers of the Ca2+ signals; compatibly, RYR3KO mice 
were reported to have a mild cognitive impairment 
when tested on a water maize (Balschun et al., 1999), 
but retrospectively, this may have also been related to a 
visual impairment. Studies aimed at understanding the 
role of RyR3 in EOMs are currently under way.
Our results concerning the expression of utrophin 
are interesting and most likely explain why in patients 
with Duchenne muscular dystrophy ocular and facial 
muscles are spared. Furthermore, the observation that 
EOMs are spared in Duchenne muscular dystrophy 
even though they exhibit a large Ca2+ influx provides 
strong evidence that controlled Ca2+ influx, per se, is 
not deleterious to skeletal muscles as recently proposed 
(Millay et al., 2009), but is actually a physiological 
mechanism used by some skeletal muscles. Utrophin 
and dystrophin share considerable sequence and struc-
tural similarity (Tinsley et al., 1992; Winder et al., 1995), 
and utrophin can associate with the dystrophin-associ-
ated complex, serving as a link between actin and the 
extracellular matrix (Matsumura et al., 1992). Interest-
ingly, in cultured myotubes, the subcellular distribution 
of utrophin differs from that of dystrophin. Indeed, and 
as previously reported (Trimarchi et al., 2006) and con-
firmed in the present study, after 7–10 d of differentia-
tion, dystrophin has a punctate membrane distribution, 
whereas utrophin has a patchy more filamentous distri-
bution concentrated within specific subcellular do-
mains. The reason for this difference is unclear but may 
reflect distinct binding partners of the two proteins. In 
mdx mice, it is believed that utrophin compensates for 
the lack of dystrophin (Wakefield et al., 2000). Based 
on our results and on the fact that mdx knocked out 
also for utrophin show EOM involvement (Baker et al., 
2006), it appears that utrophin can functionally com-
pensate in vivo for the lack of dystrophin, supporting 
the current strategies aimed at modulating utrophin 
expression in the therapy for Duchenne muscular dys-
trophy (Perkins and Davies, 2002; Chakkalakal et al., 
2005; Guiraud et al., 2015).
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Collectively, these studies show that subspecialization 
of skeletal muscles occurs through multiple factors; al-
though it is true that muscle innervation plays a promi-
nent role, the distribution of a specific muscle within a 
niche devoted to a precise physiological function is also 
important. Indeed, the term muscle allotype was pro-
posed to describe the different capacities of myogenic 
cells of different lineages to express a different subset of 
myofibrillar genes. Because EOMs, orbicularis oculi, 
and levator palpebrae (and the retractor bulbi which is 
present in some mammals but not in humans) are de-
rived from cells from a different lineage than those giv-
ing rise to limb muscles, their myogenic precursors 
must be programmed to express different subsets of 
proteins. The present study substantiates the validity of 
the muscle allotype hypothesis because we show that 
satellite cells derived from different muscles are primed 
and will follow the developmental characteristics of 
their muscle of origin, a property that can be exploited 
in laboratories devoted to tissue engineering.
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Figure S1. Voltage dependence of Ca2+ release in orbicularis oculi–derived myotubes. Orbicularis oculi–derived myotubes were 
patch clamped in the whole cell configuration and stimulated to different depolarizing potentials to elicit SR Ca2+ release as de‑
scribed in Materials and methods. (A) Three examples of stimulated Ca2+ current (lower traces), line scans imaged in the line scan 
mode using fluo‑3 and corresponding line profiles at −40 mV, −10 mV, and 10 mV, respectively. With increasing membrane depolar‑
ization, the amplitude of the triggered Ca2+ transient increases. (B) The maximal Ca2+ transient amplitudes at each tested membrane 
potential are summarized. The ECC of orbicularis oculi myotubes demonstrates a V dependence of Ca2+ release similar to that ob‑
served in quadriceps myotubes (Rokach et al., 2013). At low depolarization, a slow rise in Ca2+ initiates and leads to a Ca2+ transient 
of small amplitude. With increasing depolarization, Ca2+ release becomes faster and larger, reaching peak amplitudes at about 30 
mV. Data are normalized to the respective peak transient amplitude in each cell. The Ca2+‑voltage relationship was fitted with a 
Boltzmann function and derived a half‑maximal activation potential of approximately −25 ± 5.3 mV (n = 5–‑6 cells). Despite rapid 
coupling, the Ca2+ removal mechanisms after release appear to be very immature. As seen in the line scan images and previously 
reported in quadriceps‑derived myotubes (Rokach et al., 2013), it takes several seconds for [Ca2+]i to return to basal levels. Error 
bars indicate SEM.
Subspecialization of human ocular muscles | Sekulic‑Jablanovic et al.S14
Figure S2. Human myotubes do not show spontaneous Ca2+ release events (SPA RKS). (top) Representative photomicrographs 
of fluo‑4–loaded myotubes. (middle) Representative 2.5‑s line scan images. (bottom) Positive control showing that using similar 
settings sparks can be detected in a vascular smooth muscle cell (SMC). Bars, 20 μm. OO, orbicularis oculi; QU, quadriceps.
Table S1. Sequence of primers used for qPCR
Gene name Primer sequence (5′ to 3′)
RYR1                  F: GGA CCT CTA CGC CCT GTA TC 
                 R: ATC TCC CGC CTT AGC CAT TTT
RYR3                  F: CAG TCC CTA TCT GTC AGA GCC 
                 R: CAT GGC CGT ATA ACA GGG TCC
CAC NA1S                  F: TTG CCT ACG GCT TCT TAT TCCA 
                 R: GTT CCA GAA TCA CGG TGA AGAC
CAC NA1C                  F: TGA TTC CAA CGC CAC CAA TTC 
                 R: GAG GAG TCC ATA GGC GAT TACT
SER CA1                  F: GGT GCT GGC TGA CGA CAA CT 
                 R: AAG AGC CAG CCA CTG ATG AG
CASQ1                  F: CAC CCA AGT CAG GGG TAC AG 
                 R: GTG CCA GCA CCT CAT ACT TCT
JSRP1                  F: TGT CGC TCA ACA AGT GCC TG 
                 R: GCC TGG GCC TCG AAC TTAG
UTRN                  F: TGA AGG ATG TCA TGT CGG ACC 
                 R: GTT GAG GAC GTT GAC TTG GCT
DMD                  F: GAG ACA CAT GCG GCC TTT ATG 
                 R: CTC TAA CTC CTC AAA TGG GTGC
ACTN2                  F: GAC ATC GTG AAC ACC CCT AAAC 
                 R: CCG CAA AAG CGT GGT AGAA
MYH13                  F: GGA GAG AAT CGA GGC TCA AAA TC 
                 R: GTC TGG ATC ATG CCT TTC ACA TA
Conditions were as described in Materials and methods. F, forward; R, reverse.
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